Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI

Sag S., YILDIZ A., Kaderli A. A., Gul B. C., Bedir O., Cegilli E., ...Daha Fazla

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.55, sa.1, ss.132-138, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 55 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1515/cclm-2016-0005
  • Dergi Adı: CLINICAL CHEMISTRY AND LABORATORY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.132-138
  • Anahtar Kelimeler: contrast induced nephropathy, HDL-cholesterol, monocyte, PERCUTANEOUS CORONARY INTERVENTION, ACUTE KIDNEY INJURY, HIGH-DENSITY-LIPOPROTEIN, ELEVATION MYOCARDIAL-INFARCTION, CREATININE CLEARANCE RATIO, PRIMARY ANGIOPLASTY, CARDIOVASCULAR EVENTS, N-ACETYLCYSTEINE, RENAL-FUNCTION, RISK SCORE
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: Contrast induced nephropathy (CIN) has been proven to be a clinical condition related to adverse cardiovascular outcomes. In recent studies, the monocyte to high density lipoprotein ratio (MHR) has been-postulated as a novel parameter associated with adverse renal and cardiovascular outcomes. In this study we-investigated the association of MHR with CIN in-ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI).